Talks over iSoft bid
Australian software firm IBA Health was today in talks with investors over a potential £132.3m (€194m) offer for NHS software company iSoft.
IBA has suspended its shares on the Australian stock exchange while discussions with institutional investors over financing the possible iSoft deal continue.
Manchester-based Isoft said its management were taking part in the talks, which could lead to an all-share offer for the business.
IBA is looking to raise AUD$200m (€120m) in new equity to fund the possible deal, as well as raising AUD$315m (€191m) in debt facilities for the combined company.
